Global Surgical Glue Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Surgical Glue Market Size

• The global Surgical Glue market size was valued at USD 3.06 billion in 2025 and is expected to reach USD 6.23 billion by 2033, at a CAGR of 9.25% during the forecast period
• The market growth is largely fueled by the increasing adoption of minimally invasive surgeries, rising demand for faster wound closure solutions, and growing preference for alternatives to traditional sutures and staples in hospitals and surgical centers, leading to improved patient outcomes, reduced procedure time, and lower risk of infection
• Furthermore, rising technological advancements in bioadhesive formulations, expanding applications across cardiovascular, orthopedic, and general surgeries, and increasing awareness among healthcare providers about the benefits of surgical adhesives are establishing Surgical Glue solutions as essential tools in modern surgical procedures. These converging factors are accelerating the uptake of these products, thereby significantly boosting the industry’s growth

Surgical Glue Market Analysis

• Surgical glue, offering advanced adhesive solutions for wound closure and tissue repair, is increasingly vital in modern surgical procedures across hospitals, ambulatory centers, and specialty clinics due to its efficiency, reduced procedure time, and improved patient outcomes
• The escalating demand for surgical glue is primarily fueled by the widespread adoption of minimally invasive surgeries, growing prevalence of chronic wounds and surgical interventions, and a rising preference for faster, safer, and less invasive wound closure solutions
• North America dominated the topical skin adhesive market with the largest revenue share of approximately 41.6% in 2025, supported by advanced healthcare infrastructure, strong adoption of innovative wound closure technologies, and the presence of leading medical device manufacturers. Hospitals, ambulatory surgical centers, and emergency care units across the region are increasingly adopting topical skin adhesives for minimally invasive surgical procedures, trauma care, and outpatient wound management
• Asia-Pacific is expected to be the fastest-growing region in the topical skin adhesive market during the forecast period, registering a CAGR of approximately 9.1%, driven by expanding healthcare infrastructure, rising surgical procedure volumes, increasing awareness of advanced wound closure solutions, and growing adoption of modern wound care technologies across emerging economies such as China and India
• The Synthetic and Semi-synthetic Sealants and Adhesives segment dominated the largest market revenue share of approximately 56.2% in 2025, driven by their superior bonding strength, faster polymerization, and consistent performance in surgical procedures

Report Scope and Surgical Glue Market Segmentation         

Surgical Glue Market Trends

“Growing Need for Minimally Invasive Procedures and Advanced Wound Closure Solutions”

• The global demand for surgical glue is being driven by the increasing adoption of minimally invasive procedures that reduce patient recovery times, lower the risk of infection, and improve cosmetic outcomes compared to traditional sutures and staples
• For instance, in 2024, Ethicon (Johnson & Johnson) launched a new cyanoacrylate-based surgical adhesive for laparoscopic gastrointestinal surgeries, which significantly reduced post-operative complications and improved closure efficiency
• The rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and obesity is contributing to higher incidences of surgical interventions, which boosts the need for effective tissue adhesives
• Advancements in surgical glue formulations, including faster polymerization, superior biocompatibility, and stronger tissue adhesion, are enhancing surgeon confidence and patient outcomes, increasing global adoption
• The convenience of surgical glue, such as reduced operation time, decreased need for follow-up procedures, and improved patient comfort, is further propelling its use across hospitals, outpatient surgical centers, and ambulatory care facilities
• Increasing awareness among clinicians about the benefits of surgical adhesives in reducing post-operative complications, hematoma formation, and wound dehiscence is also accelerating market growth globally

Surgical Glue Market Dynamics

Driver

“Technological Innovations and Expanding Applications Across Surgical Specialties”

• The surgical glue market is witnessing significant technological innovation, with new delivery systems, pre-filled applicators, and advanced formulations improving ease of use, precision, and safety
• For instance, in 2025, B. Braun introduced a fibrin-based hemostatic adhesive for orthopedic procedures, which minimized intraoperative bleeding and reduced post-operative hematoma formation
• Surgical glues are increasingly being integrated with bioactive materials and absorbable scaffolds to promote tissue regeneration and accelerate wound healing
• Growth in minimally invasive and robotic-assisted surgeries is expanding the use of surgical adhesives, as these procedures require precise, sterile closure in complex anatomical areas
• New applications are emerging in ophthalmology, cardiovascular surgery, urology, and cosmetic procedures, highlighting the versatility of surgical glues beyond traditional general surgery
• Expansion into emerging markets is contributing to global growth, driven by increasing surgical volumes, rising healthcare investments, and government initiatives supporting modern wound management solutions

Restraint/Challenge

“High Costs, Regulatory Hurdles, and Limited Awareness in Emerging Markets”

• The relatively high price of advanced surgical glues compared to conventional sutures or staples remains a significant barrier to adoption, especially in cost-sensitive regions
• For instance, adoption in Southeast Asian hospitals has been slower due to price constraints and limited familiarity with fibrin-based and cyanoacrylate adhesives
• Stringent regulatory requirements across regions, such as the FDA in the U.S., EMA in Europe, and PMDA in Japan, can delay product approvals and increase research and development costs
• Limited training and awareness among healthcare professionals about optimal application techniques and benefits of surgical adhesives can hinder market penetration, particularly in developing countries
• Storage and handling challenges, including sensitivity to moisture, short shelf life, and the need for specialized applicators, create additional barriers for hospitals and surgical centers
• Potential allergic reactions or rare tissue incompatibility issues may raise concerns among clinicians, necessitating additional safety studies and product information dissemination
• Competition from alternative wound closure methods, including advanced sutures, staples, and novel wound dressings, may restrict rapid adoption in some regions until further clinical evidence supports broader use

Surgical Glue Market Scope

The Surgical Glue market is segmented on the basis of product, indication, application, and end user.

• By Product

On the basis of product, the market is segmented into Natural/Biological Sealants and Adhesives and Synthetic and Semi-synthetic Sealants and Adhesives. The Synthetic and Semi-synthetic Sealants and Adhesives segment dominated the largest market revenue share of approximately 56.2% in 2025, driven by their superior bonding strength, faster polymerization, and consistent performance in surgical procedures. These adhesives, including cyanoacrylate- and polyethylene glycol-based formulations, are widely used for tissue closure, sealing, and hemostasis. Hospitals and surgical centers prefer synthetic adhesives because they provide reliable adhesion across various tissue types while maintaining longer shelf life and easier storage conditions. Technological advancements in polymer chemistry have significantly improved adhesive flexibility, elasticity, and durability, making them suitable for minimally invasive surgeries. Surgeons increasingly adopt synthetic glues to reduce operating time and minimize complications associated with sutures and staples. Their broad use across cardiovascular, orthopedic, and plastic surgeries ensures consistent demand. Regulatory approvals and clinical guidelines supporting their use in advanced surgical procedures further strengthen adoption. In addition, growing investments in surgical innovation and hospital infrastructure support the segment’s market dominance globally.

The Natural/Biological Sealants and Adhesives segment is expected to witness the fastest CAGR of 9.1% from 2026 to 2033, fueled by rising demand for bio-compatible and biodegradable surgical materials. Biological adhesives such as fibrin-based sealants mimic the body’s natural clotting mechanisms, making them highly suitable for delicate surgeries and patients sensitive to synthetic materials. Increasing adoption in cardiac, neurosurgical, and cosmetic procedures is driving demand. These adhesives are particularly valued for their low toxicity and ability to support natural tissue regeneration. Growing patient preference for safer and biologically derived medical solutions also contributes to segment growth. Technological improvements in fibrin sealant formulation and purification processes have enhanced product safety and effectiveness. In addition, rising investments in regenerative medicine and tissue engineering research are expanding the applications of biological adhesives. Expanding healthcare infrastructure in emerging economies and increasing surgical volumes further support rapid growth in this segment.

• By Indication

On the basis of indication, the market is segmented into Tissue Sealing, Surgical Hemostasis, and Tissue Engineering. The Surgical Hemostasis segment dominated the largest market revenue share of around 47.5% in 2025, driven by the critical role of surgical glues in controlling bleeding during complex surgical procedures. Hemostatic adhesives are widely used in cardiovascular, hepatic, and orthopedic surgeries to rapidly stop bleeding and reduce the risk of complications. Hospitals and surgical centers increasingly rely on these products to improve patient outcomes and minimize blood loss during operations. Technological advancements in fibrin and polymer sealants have improved clotting speed and reliability. Surgeons prefer hemostatic adhesives due to their ease of application and compatibility with minimally invasive surgical techniques. The rising prevalence of trauma injuries and chronic diseases requiring surgery further increases demand. In addition, regulatory approvals and clinical practice guidelines recommending hemostatic sealants support strong adoption in surgical settings worldwide.

The Tissue Sealing segment is expected to witness the fastest CAGR of 9.0% from 2026 to 2033, fueled by the growing adoption of surgical adhesives for suture-less wound closure and tissue bonding. Tissue sealing adhesives are increasingly used in gastrointestinal, cosmetic, and laparoscopic procedures, offering faster wound closure and improved cosmetic outcomes. These adhesives reduce the need for sutures or staples, minimizing postoperative discomfort and scarring. Growing demand for minimally invasive surgeries and faster recovery times is accelerating segment growth. Technological innovations in adhesive formulations have improved elasticity and bonding strength, making them suitable for complex tissue structures. Hospitals and ambulatory surgical centers are increasingly incorporating tissue sealing adhesives into standard surgical kits. Rising awareness among surgeons regarding the benefits of adhesive-based closure techniques further contributes to market expansion.

• By Application

On the basis of application, the market is segmented into Cardiovascular Surgery, General Surgery, CNS Surgery, Orthopedic Surgery, Cosmetic Surgery, Urological Surgery, Pulmonary Surgery, Ophthalmic Surgery, and Other Applications. The General Surgery segment dominated the market with a revenue share of approximately 34.7% in 2025, driven by the high volume of procedures requiring reliable tissue closure and bleeding control. Surgical glues are widely used in appendectomies, hernia repairs, gastrointestinal surgeries, and other routine procedures. Hospitals frequently adopt surgical adhesives because they reduce surgical time and improve patient recovery. Technological improvements in adhesive strength and delivery systems further enhance their applicability across various procedures. The growing preference for minimally invasive surgeries and laparoscopic techniques also increases demand for advanced surgical glues. Clinical guidelines recommending adhesive-based closure methods in specific procedures support adoption. Rising patient volumes and expanding hospital infrastructure further strengthen the segment’s leadership in the market.

The Cardiovascular Surgery segment is expected to witness the fastest CAGR of 9.6% from 2026 to 2033, driven by the increasing prevalence of cardiovascular diseases and the growing number of cardiac surgical procedures worldwide. Surgical adhesives play a crucial role in vascular repair, hemostasis, and reinforcement of suture lines in heart surgeries. These adhesives help reduce bleeding complications and improve surgical outcomes in high-risk cardiac operations. Hospitals and specialized cardiac centers are increasingly adopting advanced adhesives due to their reliability and effectiveness in delicate cardiovascular tissues. Technological advancements in adhesive formulations have improved bonding strength and biocompatibility for vascular applications. Rising investments in cardiac care infrastructure and surgical innovation further accelerate segment growth. In addition, the increasing aging population and higher incidence of heart diseases are expected to drive strong demand for surgical adhesives in cardiovascular procedures.

• By End User

On the basis of end user, the market is segmented into Hospitals/Clinics, Specialty Clinics, and Ambulatory Surgical Centers. The Hospitals/Clinics segment dominated the largest revenue share of approximately 52.1% in 2025, due to the high volume of surgical procedures performed in hospital settings. Hospitals possess advanced surgical infrastructure and trained professionals capable of utilizing specialized surgical adhesives. These institutions frequently perform complex surgeries such as cardiovascular, orthopedic, and neurosurgical procedures where effective tissue sealing and hemostasis are critical. Hospitals also benefit from bulk procurement and long-term supply agreements with manufacturers, ensuring consistent availability of surgical glues. In addition, hospitals are often early adopters of innovative surgical technologies and advanced medical products. Rising patient admissions and expanding surgical departments further increase demand for surgical adhesives in hospital environments.

The Ambulatory Surgical Centers segment is expected to witness the fastest CAGR of 8.8% from 2026 to 2033, fueled by the increasing shift toward outpatient surgical procedures. Ambulatory centers prefer surgical adhesives for quick wound closure and reduced procedure times, enabling faster patient turnover. These facilities frequently perform minimally invasive and cosmetic procedures where surgical glues provide effective alternatives to traditional sutures. Growing healthcare cost-containment strategies and patient preference for shorter hospital stays support the growth of ASCs. Technological innovations in portable adhesive delivery systems also enhance their usability in outpatient settings. In addition, the increasing number of ambulatory surgical facilities worldwide further drives adoption.

Surgical Glue Market Regional Analysis

• North America dominated the surgical glue market with the largest revenue share of approximately 41.6% in 2025, supported by advanced healthcare infrastructure, strong adoption of innovative wound closure technologies, and the presence of leading medical device manufacturers. Hospitals, ambulatory surgical centers, and emergency care units across the region are increasingly adopting surgical glue for minimally invasive surgical procedures, trauma care, and outpatient wound management
• Healthcare providers in the region highly value the ability of surgical glue to provide rapid wound closure, reduce infection risks, and improve cosmetic outcomes compared with conventional sutures and staples. The growing number of surgical procedures and increasing preference for minimally invasive techniques are further supporting the adoption of surgical glue across hospitals and specialty clinics
• This widespread adoption is further supported by rising healthcare expenditure, strong research and development activities, and the increasing focus on improving surgical efficiency and patient recovery outcomes. Continuous product innovations and the presence of leading medical device companies are further strengthening the market growth across North America

U.S. Surgical Glue Market Insight

The U.S. surgical glue market captured the largest revenue share of approximately 80.5% in 2025 within North America, driven by the country’s advanced healthcare infrastructure, high volume of surgical procedures, and rapid adoption of modern wound closure technologies. Hospitals, ambulatory surgical centers, and specialized surgical clinics are increasingly utilizing surgical glue to enhance surgical efficiency and reduce procedure time. The rising number of cosmetic, reconstructive, and minimally invasive surgeries, along with increasing demand for faster wound closure methods in emergency care units, is further supporting market expansion. In addition, strong research and development activities, continuous product launches, and the presence of leading medical device companies are contributing to the growing adoption of surgical glue across the U.S. healthcare system.

Europe Surgical Glue Market Insight

The Europe surgical glue market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by the rising adoption of advanced wound closure technologies and increasing demand for minimally invasive surgical procedures. The growth in surgical volumes, coupled with increasing awareness regarding infection control and faster patient recovery, is encouraging hospitals and surgical centers to adopt surgical glue as an effective alternative to traditional sutures and staples. The region is experiencing strong adoption across hospitals, ambulatory surgical centers, and specialty clinics, particularly in procedures involving dermatology, orthopedics, and general surgery.

U.K. Surgical Glue Market Insight

The U.K. surgical glue market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by the increasing number of surgical procedures and growing adoption of minimally invasive surgical techniques. Hospitals and specialty clinics across the country are increasingly adopting surgical glue to improve surgical efficiency and enhance patient recovery outcomes. In addition, rising awareness of advanced wound care solutions and the expansion of ambulatory surgical centers are further supporting market growth in the United Kingdom.

Germany Surgical Glue Market Insight

The Germany surgical glue market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing healthcare expenditure, strong focus on surgical innovation, and growing adoption of advanced wound closure technologies. Germany’s well-established healthcare infrastructure and emphasis on high-quality medical care are encouraging hospitals and surgical centers to adopt surgical glue for various surgical applications. The increasing demand for efficient wound management solutions and improved surgical outcomes is further supporting market growth in the country.

Asia-Pacific Surgical Glue Market Insight

The Asia-Pacific surgical glue market is poised to grow at the fastest CAGR of approximately 9.1% during the forecast period, driven by expanding healthcare infrastructure, rising surgical procedure volumes, and increasing awareness of advanced wound closure solutions across emerging economies such as China, Japan, and India. The region’s growing focus on improving healthcare access and strengthening hospital infrastructure is accelerating the adoption of modern surgical technologies, including surgical glue.

Japan Surgical Glue Market Insight

The Japan surgical glue market is gaining momentum due to the country’s advanced healthcare system, increasing number of surgical procedures, and strong adoption of modern medical technologies. Hospitals and specialized surgical centers are increasingly utilizing surgical glue to enhance surgical precision and improve patient recovery outcomes. In addition, the growing aging population and rising prevalence of chronic conditions requiring surgical intervention are further driving the demand for surgical glue in Japan.

China Surgical Glue Market Insight

The China surgical glue market accounted for the largest market revenue share in Asia-Pacific in 2025, attributed to the country’s rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising number of surgical procedures. China’s large patient population and growing demand for advanced wound care technologies are encouraging hospitals and surgical centers to adopt surgical glue for various surgical applications. Furthermore, the presence of domestic medical device manufacturers and increasing investments in healthcare facilities are contributing to the strong growth of the surgical glue market in China.

Surgical Glue Market Share

The Surgical Glue industry is primarily led by well-established companies, including:

• Baxter International (U.S.)
• Terumo Corporation (Japan)
• Johnson & Johnson (U.S.)
• Medtronic (Ireland)
• H.B. Fuller (U.S.)
• PolyNovo (Australia)
• Arthrex (U.S.)
• GEM Biomedical (France)
• Bioglue (U.S.)
• SyntheMed (U.S.)
• Cohera Medical (U.S.)
• LeMaitre Vascular (U.S.)
• Advanced Medical Solutions (U.K.)
• Hemostasis LLC (U.S.)
• Medline Industries (U.S.)
• Indermil Biotech (Germany)

Latest Developments in Global Surgical Glue Market

• In July 2021, Baxter International Inc. acquired the PerClot polysaccharide hemostatic system, strengthening its advanced surgical portfolio by adding a highly effective bleeding control product that complements surgical glue and adhesive technologies used during procedures requiring rapid hemostasis
• In February 2023, Advanced Medical Solutions Group plc announced the acquisition of Connexicon Medical Limited, a Dublin‑based tissue adhesive technology specialist, boosting its capabilities in surgical glue solutions, especially cyanoacrylate‑based adhesives used for skin and soft tissue closure
• In August 2023, Johnson & Johnson launched a new generation of absorbable medical glue designed to enhance tissue adhesion and reduce complications during surgery, leveraging advanced polymer technology to improve surgical outcomes across multiple specialties including minimally invasive procedure
• In July 2023, B. Braun Melsungen AG entered into a strategic partnership to co‑develop new absorbable adhesive technology targeting orthopedic surgical applications, combining its surgical product expertise with advanced bioadhesive innovation
• In March 2024, TELA Bio, Inc. launched LIQUIFIX FIX8, the first adhesive‑based product for hernia mesh fixation that eliminates the need for mechanical fasteners, reducing patient discomfort and expanding surgical glue applications into soft tissue reinforcement
• In August 2024, Resivant Medical secured U.S. FDA 510(k) clearance for Cutiva Topical Skin Adhesive and Cutiva PLUS Skin Closure System, representing a major regulatory milestone that brings new advanced sutureless wound closure solutions to clinical practice
• In April 2025, Baxter International launched the Hemopatch Sealing Hemostat with room‑temperature storage, a surgical adhesive designed to improve bleeding control and leak prevention in operative settings with enhanced accessibility

SKU-18803